ALVOTECH SA

Lobbying client · filed 2025 to 2026

Biosimilar medicine development and manufacture

$70,000 Reported spend

4 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 4 filings. Everything on this page is grouped by the client's LDA id (70469), not by name.

Firms hired 1

HOLLAND & KNIGHT LLP $70,000 4 filings

Reported by year 2 years

2026 $50,000 2 filings
2025 $20,000 2 filings

Issues lobbied 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 1

U.S. Trade Representative (USTR) 1

Recent filings 4 total

Q2Y

HOLLAND & KNIGHT LLP

2nd Quarter (Apr 1 - June 30) 2026 · posted Jul 15, 2026

View → Q1

HOLLAND & KNIGHT LLP

1st Quarter (Jan 1 - Mar 31) 2026 · $50,000 income · posted Apr 17, 2026

View → Q4

HOLLAND & KNIGHT LLP

4th Quarter (Oct 1 - Dec 31) 2025 · $20,000 income · posted Jan 18, 2026

View → RR

HOLLAND & KNIGHT LLP

4th Quarter (Oct 1 - Dec 31) 2025 · posted Jan 9, 2026

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.